Tuesday, May 24, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DCN Diagnostics and E25Bio Partner on Point-of-Care Diagnostics

by Global Biodefense Staff
September 28, 2018
Biodefense News - Industry Updates

DCN Dx, a developer and manufacturer of rapid point-of-care diagnostic tests, and E25Bio, an MIT-spinoff diagnostics company from the Gehrke Lab at IMES, have announced a partnership for the design, development and manufacture of an innovative new infectious disease testing technology.

This new technology is a rapid, low-cost, highly-specific and sensitive method for onsite detection and global epidemiological analysis of dengue, Chikungunya and Zika viruses in one device.

DCN will develop the technology into a highly-functional and accessible multiplexed product that can be deployed for in-field use around the world. E25Bio’s mission is to prevent severe downstream health outcomes through affordable and early detection. The organization is currently funded by The Engine.

“With 3.8 billion people in endemic areas and 128 countries affected by mosquito-borne viruses, swift diagnostics are crucial for patient treatment and the management of epidemics. The low cost of E25Bio’s RDT technology makes the point-of-care test more accessible to communities worldwide.”

– Irene Bosch, PhD, E25Bio’s CEO & Founder

Mobile and rapid diagnostics can facilitate real-time reporting, providing large datasets to guide the response to disease outbreaks.

E25Bio is an enterprise for innovation in the field of emerging disease diagnostics founded by Dr. Irene Bosch and MIT Professor Lee Gehrke.

Tags: ChikungunyaDenguePOC DiagnosticsZika

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization
Biodetection

Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization

March 19, 2022
There’s No Such Thing as Just-in-Time Healthcare and Public Health Preparedness
Industry News

Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate

March 3, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC